DiaMedica Therapeutics Announces 2024 Financial Results and Business Update
March 17, 2025 - 23:55
MINNEAPOLIS, March 17, 2025—DiaMedica Therapeutics Inc., a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for acute ischemic stroke and preeclampsia, has released its financial results for the year ending December 31, 2024. The company outlined its strategic initiatives and progress made over the past year, highlighting advancements in their clinical programs.
With a focus on addressing significant unmet medical needs, DiaMedica has made strides in its research efforts, particularly in the areas of acute ischemic stroke and preeclampsia. The company is committed to advancing its pipeline and believes that its innovative therapies have the potential to transform patient outcomes.
To further discuss these developments and the financial results, management will conduct a conference call on Tuesday, March 18, 2025, at 8:00 AM Eastern Time. This call will provide an opportunity for stakeholders to gain insights into the company’s future plans and ongoing projects.
MORE NEWS
September 3, 2025 - 07:58
Insights from Guming Holdings' CFO on Strategy and Chinese Consumer TrendsGeorge Meng, the Chief Financial Officer of Guming Holdings, recently shared insights into the company`s evolving business strategy and the outlook for Chinese consumers. Speaking during the...
September 2, 2025 - 20:51
New Federal Legislation Seeks to Alleviate Regulatory Burdens for Small BusinessesIn a significant move to support small business owners, Rep. Tony Wied from Green Bay is advocating for federal legislation that shifts the focus from stringent regulations to fostering growth and...
September 2, 2025 - 00:03
Treasury Secretary Signals Potential for New Sanctions Against RussiaTreasury Secretary Scott Bessent has indicated that the United States is considering a wide range of options for imposing sanctions on Russia in response to its recent bombings in Ukraine. This...
September 1, 2025 - 02:56
Trump Administration Considers Supreme Court Appeal Following Controversial Tariff RulingIn a significant development, a 7-4 ruling by a federal appeals court has prompted the Trump administration to contemplate an appeal to the Supreme Court regarding tariffs. Peter Navarro, a...